[go: up one dir, main page]

NO995900L - Retroviral vector particles formed in a baculovirus expression system - Google Patents

Retroviral vector particles formed in a baculovirus expression system

Info

Publication number
NO995900L
NO995900L NO995900A NO995900A NO995900L NO 995900 L NO995900 L NO 995900L NO 995900 A NO995900 A NO 995900A NO 995900 A NO995900 A NO 995900A NO 995900 L NO995900 L NO 995900L
Authority
NO
Norway
Prior art keywords
expression system
retroviral vector
particles formed
baculovirus expression
vector particles
Prior art date
Application number
NO995900A
Other languages
Norwegian (no)
Other versions
NO995900D0 (en
Inventor
Alan John Kingsman
Ian Martin Jones
Original Assignee
Oxford Biomedica Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Biomedica Ltd filed Critical Oxford Biomedica Ltd
Publication of NO995900D0 publication Critical patent/NO995900D0/en
Publication of NO995900L publication Critical patent/NO995900L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14144—Chimeric viral vector comprising heterologous viral elements for production of another viral vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13051—Methods of production or purification of viral material
    • C12N2740/13052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15051—Methods of production or purification of viral material
    • C12N2740/15052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

En sammensetning er beskrevet. Sammensetningen omfatter minst en baculoviral komponent og minst en retroviral komponent, hvor den retrovirale komponent kan pakkes inn i en retroviral partikkel.A composition is described. The composition comprises at least one baculoviral component and at least one retroviral component, wherein the retroviral component can be packed into a retroviral particle.

NO995900A 1997-06-04 1999-12-02 Retroviral vector particles formed in a baculovirus expression system NO995900L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9711578.6A GB9711578D0 (en) 1997-06-04 1997-06-04 Novel retroviral vector production systems
PCT/GB1998/001626 WO1998055640A1 (en) 1997-06-04 1998-06-04 Retroviral vector particles produced in a baculovirus expression system

Publications (2)

Publication Number Publication Date
NO995900D0 NO995900D0 (en) 1999-12-02
NO995900L true NO995900L (en) 2000-02-04

Family

ID=10813571

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995900A NO995900L (en) 1997-06-04 1999-12-02 Retroviral vector particles formed in a baculovirus expression system

Country Status (11)

Country Link
EP (1) EP0986649A1 (en)
JP (1) JP2002510204A (en)
KR (1) KR20010013332A (en)
CN (1) CN1259171A (en)
AU (1) AU741764B2 (en)
CA (1) CA2289491A1 (en)
GB (1) GB9711578D0 (en)
IL (1) IL132359A0 (en)
NO (1) NO995900L (en)
NZ (1) NZ500936A (en)
WO (1) WO1998055640A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5448400A (en) * 1999-05-28 2000-12-18 Mount Sinai School Of Medicine, The A novel baculovirus/adenovirus hybrid vector for the rescue, production and titration of high-capacity adenovirus amplicon vectors
EP1399585B1 (en) 2000-10-23 2008-02-20 Gen-Probe Incorporated Compositions and methods for detecting human immunodeficiency virus 2 (hiv-2)
US9333249B2 (en) 2006-02-09 2016-05-10 Educational Foundation Jichi Medical University Recombinant baculovirus vaccine
TWI477602B (en) 2006-02-09 2015-03-21 Educational Foundation Jichi Medical Univ Novel viral vector
GB0702695D0 (en) * 2007-02-12 2007-03-21 Ark Therapeutics Ltd Production of vectors
CN101952436B (en) 2008-01-09 2013-03-13 建国大学校产学协力团 Baculovirus-based vaccines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE170557T1 (en) * 1987-07-24 1998-09-15 Chiron Corp BREEDING INSECT CELLS USING AIRLIFT REACTORS
JPH03504079A (en) * 1988-03-21 1991-09-12 カイロン　コーポレイション recombinant retrovirus
WO1991019803A1 (en) * 1990-06-19 1991-12-26 Applied Biotechnology, Incorporated Self assembled, defective, nonself-propagating viral particles
GB9510272D0 (en) * 1995-05-22 1995-07-19 Isis Innovation Retroviral vectors

Also Published As

Publication number Publication date
EP0986649A1 (en) 2000-03-22
CA2289491A1 (en) 1998-12-10
NZ500936A (en) 2001-11-30
GB9711578D0 (en) 1997-07-30
CN1259171A (en) 2000-07-05
KR20010013332A (en) 2001-02-26
AU7780098A (en) 1998-12-21
AU741764B2 (en) 2001-12-06
JP2002510204A (en) 2002-04-02
NO995900D0 (en) 1999-12-02
WO1998055640A1 (en) 1998-12-10
IL132359A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
ATE224183T1 (en) CONDITIONING SHAMPOO COMPOSITION
DE69515891D1 (en) COMPOSITE AND SUCTIONABLE LAUNDRY PIECE WITH THIS COMPOSITE
DE69607952D1 (en) ORGANOBORAN-POLYAMINE COMPLEXES AND ADHESIVE COMPOSITIONS PRODUCED WITH THEM
AU134374S (en) Container for wipes or the like
HUP0004929A3 (en) Cellulosic based polymers, detergent and laundry additive composition containing the same
DE69106714D1 (en) Hypoglykämische hydroxyharnstoffderivate.
FI960717A (en) Polyolefin blends and their processing in the solid state
DE69801976D1 (en) Composition and article with improved compression set
BG101105A (en) Substituted benzamidines, their preparation and application as medicamentous forms
GB2285806B (en) Alkali-treated bagasse,and its preparation and uses
ID29052A (en) 3,3-BIARILPIPERIDINE AND 2,2-BIARILMORPHOLINA DECREASES
AP9801289A0 (en) Proc ss fo prep ring ,4-di ydroxypy-ridine and 2,4-dihydroxy-3-nitropyridine
MX240950B (en) An absorbent structure in an absorbent article, comprising a partially neutralised superabsorbent material, and an absorbent article that comprises the absorbent structure.
DE69006878D1 (en) Particulate detergent additive, its manufacture and use in detergent compositions.
FR2753978B1 (en) THERMOSETTING COMPOSITION, USES THEREOF AND FOLDABLE FLEXIBLE PREFORM COMPRISING THE SAME
NO995900L (en) Retroviral vector particles formed in a baculovirus expression system
DK1101053T3 (en) Double ring seal in one piece
DE69528571D1 (en) FILLING HOLES AND THE LIKE IN SUBSTRATES
ZA969402B (en) Novel oligopeptides, the preparation and use thereof.
EP0827082A4 (en) Semiconductor memory having arithmetic function, and processor using the same
AU7310191A (en) Photoluminescent materials, particularly for coating various surfaces, and uses thereof
ES1026518Y (en) BUCKET WITH DRAINER AND PERFECTED MOCHO.
GR3034675T3 (en) Polymer composition, the production and further processing thereof into receptacles
IL116164A0 (en) Proteins having fibrinolytic and thrombin-inhibiting properties
ES2195405T3 (en) DERIVED FROM TIADIAZOL CARBOXAMIDA, PHYTOSANITARY AGENT, AND USE.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application